Director/PDMR Shareholding

RNS Number : 7997Q

Hikma Pharmaceuticals Plc

08 June 2018

 

Hikma Pharmaceuticals PLC - EIP Awards

LONDON, 8 June 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee has made the following nil cost option under the Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan (the "EIP") to a Person Discharging Managerial Responsibility ("PDMR") of the Company.

The Award under the EIP was made on 7 June 2018 at a price of 1,035 pence per Ordinary Share (being the average price for the 30-day period prior to 31 December 2017, in accordance with the EIP rules) as follows:

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Surendera Tyagi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Surendera Tyagi
2	Reason for the notification
a)	Position/status	Chief Scientific Officer and Global Head of R&D
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	The Company granted the named individual above a nil-cost option award to acquire Shares under Element C of the 2014 Executive Incentive Plan (EIP). Shares under Element C EIP award will vest after 3 years, subject to continued employment.
c)	Price(s) and volume(s)	Price(s): £10.35 Volume(s): 28,818
d)	Aggregated information	N/A
e)	Date of the transaction	7 June 2018
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

 

END

 

 

DSHBGGDLLSGBGII